nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—ABCC8—type 2 diabetes mellitus	0.0621	0.587	CbGaD
Glimepiride—Sulfonylurea Compounds—Glipizide—type 2 diabetes mellitus	0.0615	0.21	CiPCiCtD
Glimepiride—Sulfonylurea Compounds—Tolazamide—type 2 diabetes mellitus	0.0615	0.21	CiPCiCtD
Glimepiride—Sulfonylurea Compounds—Chlorpropamide—type 2 diabetes mellitus	0.0615	0.21	CiPCiCtD
Glimepiride—Sulfonylurea Compounds—Tolbutamide—type 2 diabetes mellitus	0.0615	0.21	CiPCiCtD
Glimepiride—Gliclazide—type 2 diabetes mellitus	0.0493	0.217	CrCtD
Glimepiride—Tolbutamide—type 2 diabetes mellitus	0.0493	0.217	CrCtD
Glimepiride—Glipizide—type 2 diabetes mellitus	0.0493	0.217	CrCtD
Glimepiride—Sulfonylurea Compounds—Glyburide—type 2 diabetes mellitus	0.0466	0.159	CiPCiCtD
Glimepiride—Chlorpropamide—type 2 diabetes mellitus	0.0451	0.198	CrCtD
Glimepiride—KCNJ11—type 2 diabetes mellitus	0.0438	0.413	CbGaD
Glimepiride—Glyburide—type 2 diabetes mellitus	0.0342	0.15	CrCtD
Glimepiride—KCNJ1—Tolazamide—type 2 diabetes mellitus	0.0215	0.131	CbGbCtD
Glimepiride—KCNJ1—Tolbutamide—type 2 diabetes mellitus	0.0124	0.0752	CbGbCtD
Glimepiride—ABCC8—Tolazamide—type 2 diabetes mellitus	0.0117	0.0712	CbGbCtD
Glimepiride—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0101	0.0615	CbGbCtD
Glimepiride—ABCC8—Glipizide—type 2 diabetes mellitus	0.00954	0.058	CbGbCtD
Glimepiride—Gliquidone—Glipizide—type 2 diabetes mellitus	0.0092	0.0607	CrCrCtD
Glimepiride—ABCC8—Gliclazide—type 2 diabetes mellitus	0.00887	0.054	CbGbCtD
Glimepiride—ABCC8—Repaglinide—type 2 diabetes mellitus	0.00834	0.0507	CbGbCtD
Glimepiride—KCNJ11—Glipizide—type 2 diabetes mellitus	0.00825	0.0502	CbGbCtD
Glimepiride—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.00767	0.0466	CbGbCtD
Glimepiride—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.00754	0.0459	CbGbCtD
Glimepiride—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.00721	0.0438	CbGbCtD
Glimepiride—KCNJ1—Glyburide—type 2 diabetes mellitus	0.0071	0.0432	CbGbCtD
Glimepiride—ABCC8—Tolbutamide—type 2 diabetes mellitus	0.00672	0.0409	CbGbCtD
Glimepiride—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.00652	0.0397	CbGbCtD
Glimepiride—Gliquidone—Glyburide—type 2 diabetes mellitus	0.00638	0.0421	CrCrCtD
Glimepiride—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.00581	0.0353	CbGbCtD
Glimepiride—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00572	0.0348	CbGbCtD
Glimepiride—Glipizide—Tolazamide—type 2 diabetes mellitus	0.00557	0.0368	CrCrCtD
Glimepiride—Tolbutamide—Tolazamide—type 2 diabetes mellitus	0.00557	0.0368	CrCrCtD
Glimepiride—Gliclazide—Tolazamide—type 2 diabetes mellitus	0.00557	0.0368	CrCrCtD
Glimepiride—Glipizide—Tolbutamide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Glipizide—Gliclazide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Gliclazide—Glipizide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Gliclazide—Tolbutamide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Tolbutamide—Glipizide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Tolbutamide—Gliclazide—type 2 diabetes mellitus	0.00528	0.0349	CrCrCtD
Glimepiride—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.00507	0.0335	CrCrCtD
Glimepiride—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00494	0.03	CbGbCtD
Glimepiride—Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.00483	0.0319	CrCrCtD
Glimepiride—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.00483	0.0319	CrCrCtD
Glimepiride—Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.00483	0.0319	CrCrCtD
Glimepiride—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.00481	0.0317	CrCrCtD
Glimepiride—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.00481	0.0317	CrCrCtD
Glimepiride—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.00481	0.0317	CrCrCtD
Glimepiride—Glyburide—Tolazamide—type 2 diabetes mellitus	0.00466	0.0308	CrCrCtD
Glimepiride—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.00466	0.0308	CrCrCtD
Glimepiride—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.00442	0.0292	CrCrCtD
Glimepiride—Glyburide—Gliclazide—type 2 diabetes mellitus	0.00442	0.0292	CrCrCtD
Glimepiride—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.00442	0.0292	CrCrCtD
Glimepiride—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.00442	0.0292	CrCrCtD
Glimepiride—Glyburide—Glipizide—type 2 diabetes mellitus	0.00442	0.0292	CrCrCtD
Glimepiride—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.0044	0.029	CrCrCtD
Glimepiride—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00404	0.0267	CrCrCtD
Glimepiride—ABCC8—Glyburide—type 2 diabetes mellitus	0.00386	0.0235	CbGbCtD
Glimepiride—Gliclazide—Glyburide—type 2 diabetes mellitus	0.00366	0.0242	CrCrCtD
Glimepiride—Glipizide—Glyburide—type 2 diabetes mellitus	0.00366	0.0242	CrCrCtD
Glimepiride—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00334	0.0203	CbGbCtD
Glimepiride—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.00333	0.022	CrCrCtD
Glimepiride—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.00306	0.0202	CrCrCtD
Glimepiride—ABCC8—penis—type 2 diabetes mellitus	0.00102	0.305	CbGeAlD
Glimepiride—CYP2C9—Glipizide—type 2 diabetes mellitus	0.000968	0.00589	CbGbCtD
Glimepiride—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0009	0.00547	CbGbCtD
Glimepiride—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.000765	0.00465	CbGbCtD
Glimepiride—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.000765	0.00465	CbGbCtD
Glimepiride—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.000706	0.00429	CbGbCtD
Glimepiride—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.000682	0.00415	CbGbCtD
Glimepiride—CYP2C9—Valsartan—type 2 diabetes mellitus	0.000624	0.00379	CbGbCtD
Glimepiride—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00058	0.00353	CbGbCtD
Glimepiride—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.000556	0.00338	CbGbCtD
Glimepiride—CYP2C9—Glyburide—type 2 diabetes mellitus	0.000392	0.00238	CbGbCtD
Glimepiride—CYP2C9—Losartan—type 2 diabetes mellitus	0.000358	0.00218	CbGbCtD
Glimepiride—KCNJ1—nephron tubule—type 2 diabetes mellitus	0.000327	0.0979	CbGeAlD
Glimepiride—KCNJ1—kidney—type 2 diabetes mellitus	0.000287	0.086	CbGeAlD
Glimepiride—KCNJ1—cortex of kidney—type 2 diabetes mellitus	0.000279	0.0838	CbGeAlD
Glimepiride—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000246	0.0737	CbGeAlD
Glimepiride—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000227	0.0679	CbGeAlD
Glimepiride—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000178	0.0533	CbGeAlD
Glimepiride—KCNJ11—pancreas—type 2 diabetes mellitus	0.000173	0.0518	CbGeAlD
Glimepiride—ABCC8—cardiovascular system—type 2 diabetes mellitus	0.000164	0.0491	CbGeAlD
Glimepiride—ABCC8—kidney—type 2 diabetes mellitus	0.00016	0.0481	CbGeAlD
Glimepiride—ABCC8—pancreas—type 2 diabetes mellitus	0.000159	0.0477	CbGeAlD
Glimepiride—Gliquidone—ABCC8—type 2 diabetes mellitus	0.000132	0.119	CrCbGaD
Glimepiride—Glisoxepide—ABCC8—type 2 diabetes mellitus	9.57e-05	0.0863	CrCbGaD
Glimepiride—Gliquidone—KCNJ11—type 2 diabetes mellitus	9.33e-05	0.0841	CrCbGaD
Glimepiride—Glipizide—ABCC8—type 2 diabetes mellitus	8.18e-05	0.0738	CrCbGaD
Glimepiride—Gliclazide—ABCC8—type 2 diabetes mellitus	7.6e-05	0.0686	CrCbGaD
Glimepiride—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.32e-05	0.022	CbGeAlD
Glimepiride—Glisoxepide—KCNJ11—type 2 diabetes mellitus	6.74e-05	0.0608	CrCbGaD
Glimepiride—Chlorpropamide—ABCC8—type 2 diabetes mellitus	5.91e-05	0.0533	CrCbGaD
Glimepiride—Glipizide—KCNJ11—type 2 diabetes mellitus	5.76e-05	0.052	CrCbGaD
Glimepiride—Tolbutamide—ABCC8—type 2 diabetes mellitus	5.76e-05	0.052	CrCbGaD
Glimepiride—Glyburide—CPT1A—type 2 diabetes mellitus	5.76e-05	0.052	CrCbGaD
Glimepiride—Gliclazide—KCNJ11—type 2 diabetes mellitus	5.36e-05	0.0483	CrCbGaD
Glimepiride—CYP2C9—liver—type 2 diabetes mellitus	4.53e-05	0.0136	CbGeAlD
Glimepiride—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	4.17e-05	0.0376	CrCbGaD
Glimepiride—Gliclazide—VEGFA—type 2 diabetes mellitus	4.15e-05	0.0375	CrCbGaD
Glimepiride—Tolbutamide—KCNJ11—type 2 diabetes mellitus	4.06e-05	0.0366	CrCbGaD
Glimepiride—Glyburide—ABCC8—type 2 diabetes mellitus	3.99e-05	0.036	CrCbGaD
Glimepiride—Glipizide—PPARG—type 2 diabetes mellitus	3.19e-05	0.0288	CrCbGaD
Glimepiride—Glyburide—KCNJ11—type 2 diabetes mellitus	2.81e-05	0.0254	CrCbGaD
Glimepiride—Glyburide—ABCC2—type 2 diabetes mellitus	1.52e-05	0.0137	CrCbGaD
Glimepiride—Glipizide—CYP3A4—type 2 diabetes mellitus	1.38e-05	0.0124	CrCbGaD
Glimepiride—Erythema—Losartan—type 2 diabetes mellitus	1.19e-05	0.000305	CcSEcCtD
Glimepiride—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	1.19e-05	0.000304	CcSEcCtD
Glimepiride—Headache—Glipizide—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Glimepiride—Tremor—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Glimepiride—Palpitations—Metformin—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Glimepiride—Insomnia—Gliclazide—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Glimepiride—Shock—Valsartan—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Glimepiride—Loss of consciousness—Metformin—type 2 diabetes mellitus	1.18e-05	0.000302	CcSEcCtD
Glimepiride—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	1.18e-05	0.000301	CcSEcCtD
Glimepiride—Paraesthesia—Gliclazide—type 2 diabetes mellitus	1.18e-05	0.000301	CcSEcCtD
Glimepiride—Hepatitis—Ramipril—type 2 diabetes mellitus	1.18e-05	0.0003	CcSEcCtD
Glimepiride—Anaemia—Irbesartan—type 2 diabetes mellitus	1.17e-05	0.000299	CcSEcCtD
Glimepiride—Tension—Losartan—type 2 diabetes mellitus	1.17e-05	0.000299	CcSEcCtD
Glimepiride—Dyspnoea—Gliclazide—type 2 diabetes mellitus	1.17e-05	0.000298	CcSEcCtD
Glimepiride—Dizziness—Sitagliptin—type 2 diabetes mellitus	1.17e-05	0.000298	CcSEcCtD
Glimepiride—Agitation—Irbesartan—type 2 diabetes mellitus	1.17e-05	0.000298	CcSEcCtD
Glimepiride—Somnolence—Gliclazide—type 2 diabetes mellitus	1.17e-05	0.000298	CcSEcCtD
Glimepiride—Hypertension—Metformin—type 2 diabetes mellitus	1.16e-05	0.000296	CcSEcCtD
Glimepiride—Urticaria—Glyburide—type 2 diabetes mellitus	1.16e-05	0.000296	CcSEcCtD
Glimepiride—Nervousness—Losartan—type 2 diabetes mellitus	1.16e-05	0.000296	CcSEcCtD
Glimepiride—Angioedema—Irbesartan—type 2 diabetes mellitus	1.16e-05	0.000296	CcSEcCtD
Glimepiride—Abdominal pain—Glyburide—type 2 diabetes mellitus	1.16e-05	0.000295	CcSEcCtD
Glimepiride—Dyspepsia—Gliclazide—type 2 diabetes mellitus	1.15e-05	0.000295	CcSEcCtD
Glimepiride—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	1.15e-05	0.000294	CcSEcCtD
Glimepiride—Anorexia—Valsartan—type 2 diabetes mellitus	1.15e-05	0.000293	CcSEcCtD
Glimepiride—Asthenia—Bromocriptine—type 2 diabetes mellitus	1.15e-05	0.000293	CcSEcCtD
Glimepiride—Headache—Pioglitazone—type 2 diabetes mellitus	1.14e-05	0.000291	CcSEcCtD
Glimepiride—Leukopenia—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.00029	CcSEcCtD
Glimepiride—Visual impairment—Ramipril—type 2 diabetes mellitus	1.13e-05	0.000289	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	1.13e-05	0.000289	CcSEcCtD
Glimepiride—Fatigue—Gliclazide—type 2 diabetes mellitus	1.13e-05	0.000289	CcSEcCtD
Glimepiride—Nausea—Glipizide—type 2 diabetes mellitus	1.13e-05	0.000288	CcSEcCtD
Glimepiride—Hypotension—Valsartan—type 2 diabetes mellitus	1.13e-05	0.000287	CcSEcCtD
Glimepiride—Vision blurred—Losartan—type 2 diabetes mellitus	1.13e-05	0.000287	CcSEcCtD
Glimepiride—Vomiting—Sitagliptin—type 2 diabetes mellitus	1.12e-05	0.000286	CcSEcCtD
Glimepiride—Tremor—Losartan—type 2 diabetes mellitus	1.12e-05	0.000285	CcSEcCtD
Glimepiride—Gliclazide—ALB—type 2 diabetes mellitus	1.12e-05	0.0101	CrCbGaD
Glimepiride—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	1.12e-05	0.000285	CcSEcCtD
Glimepiride—Rash—Sitagliptin—type 2 diabetes mellitus	1.11e-05	0.000284	CcSEcCtD
Glimepiride—Dermatitis—Sitagliptin—type 2 diabetes mellitus	1.11e-05	0.000284	CcSEcCtD
Glimepiride—Erythema multiforme—Ramipril—type 2 diabetes mellitus	1.11e-05	0.000284	CcSEcCtD
Glimepiride—Headache—Sitagliptin—type 2 diabetes mellitus	1.11e-05	0.000282	CcSEcCtD
Glimepiride—Anaemia—Losartan—type 2 diabetes mellitus	1.1e-05	0.000282	CcSEcCtD
Glimepiride—Agitation—Losartan—type 2 diabetes mellitus	1.1e-05	0.00028	CcSEcCtD
Glimepiride—Hypertension—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.00028	CcSEcCtD
Glimepiride—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.09e-05	0.000279	CcSEcCtD
Glimepiride—Angioedema—Losartan—type 2 diabetes mellitus	1.09e-05	0.000278	CcSEcCtD
Glimepiride—Insomnia—Valsartan—type 2 diabetes mellitus	1.09e-05	0.000278	CcSEcCtD
Glimepiride—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.08e-05	0.000276	CcSEcCtD
Glimepiride—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.08e-05	0.000276	CcSEcCtD
Glimepiride—Shock—Metformin—type 2 diabetes mellitus	1.08e-05	0.000275	CcSEcCtD
Glimepiride—Insomnia—Orlistat—type 2 diabetes mellitus	1.08e-05	0.000275	CcSEcCtD
Glimepiride—Anxiety—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000275	CcSEcCtD
Glimepiride—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.08e-05	0.000275	CcSEcCtD
Glimepiride—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.07e-05	0.000274	CcSEcCtD
Glimepiride—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.07e-05	0.000274	CcSEcCtD
Glimepiride—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.07e-05	0.000274	CcSEcCtD
Glimepiride—Somnolence—Valsartan—type 2 diabetes mellitus	1.07e-05	0.000273	CcSEcCtD
Glimepiride—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.07e-05	0.000273	CcSEcCtD
Glimepiride—Leukopenia—Losartan—type 2 diabetes mellitus	1.07e-05	0.000273	CcSEcCtD
Glimepiride—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.06e-05	0.000271	CcSEcCtD
Glimepiride—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.06e-05	0.000271	CcSEcCtD
Glimepiride—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.06e-05	0.00027	CcSEcCtD
Glimepiride—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.06e-05	0.00027	CcSEcCtD
Glimepiride—Palpitations—Losartan—type 2 diabetes mellitus	1.06e-05	0.000269	CcSEcCtD
Glimepiride—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000268	CcSEcCtD
Glimepiride—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.05e-05	0.000268	CcSEcCtD
Glimepiride—Nausea—Sitagliptin—type 2 diabetes mellitus	1.05e-05	0.000268	CcSEcCtD
Glimepiride—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.05e-05	0.000267	CcSEcCtD
Glimepiride—Asthenia—Glyburide—type 2 diabetes mellitus	1.05e-05	0.000267	CcSEcCtD
Glimepiride—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.05e-05	0.000267	CcSEcCtD
Glimepiride—Anorexia—Metformin—type 2 diabetes mellitus	1.05e-05	0.000267	CcSEcCtD
Glimepiride—Urticaria—Gliclazide—type 2 diabetes mellitus	1.04e-05	0.000266	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.04e-05	0.000265	CcSEcCtD
Glimepiride—Fatigue—Valsartan—type 2 diabetes mellitus	1.04e-05	0.000265	CcSEcCtD
Glimepiride—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.04e-05	0.000265	CcSEcCtD
Glimepiride—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000264	CcSEcCtD
Glimepiride—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.04e-05	0.000264	CcSEcCtD
Glimepiride—Pruritus—Glyburide—type 2 diabetes mellitus	1.03e-05	0.000264	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000262	CcSEcCtD
Glimepiride—Fatigue—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000262	CcSEcCtD
Glimepiride—Hypotension—Metformin—type 2 diabetes mellitus	1.03e-05	0.000262	CcSEcCtD
Glimepiride—Malnutrition—Ramipril—type 2 diabetes mellitus	1.02e-05	0.000261	CcSEcCtD
Glimepiride—Erythema—Ramipril—type 2 diabetes mellitus	1.02e-05	0.000261	CcSEcCtD
Glimepiride—Shock—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.00026	CcSEcCtD
Glimepiride—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.02e-05	0.000259	CcSEcCtD
Glimepiride—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000259	CcSEcCtD
Glimepiride—Anxiety—Losartan—type 2 diabetes mellitus	1.01e-05	0.000259	CcSEcCtD
Glimepiride—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000258	CcSEcCtD
Glimepiride—Rash—Bromocriptine—type 2 diabetes mellitus	1.01e-05	0.000257	CcSEcCtD
Glimepiride—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.01e-05	0.000257	CcSEcCtD
Glimepiride—Tension—Ramipril—type 2 diabetes mellitus	1.01e-05	0.000256	CcSEcCtD
Glimepiride—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1e-05	0.000255	CcSEcCtD
Glimepiride—Headache—Bromocriptine—type 2 diabetes mellitus	1e-05	0.000255	CcSEcCtD
Glimepiride—Diarrhoea—Glyburide—type 2 diabetes mellitus	1e-05	0.000255	CcSEcCtD
Glimepiride—Nervousness—Ramipril—type 2 diabetes mellitus	9.95e-06	0.000254	CcSEcCtD
Glimepiride—Dry mouth—Losartan—type 2 diabetes mellitus	9.95e-06	0.000254	CcSEcCtD
Glimepiride—Anorexia—Irbesartan—type 2 diabetes mellitus	9.87e-06	0.000252	CcSEcCtD
Glimepiride—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.86e-06	0.000251	CcSEcCtD
Glimepiride—Paraesthesia—Metformin—type 2 diabetes mellitus	9.86e-06	0.000251	CcSEcCtD
Glimepiride—Confusional state—Losartan—type 2 diabetes mellitus	9.83e-06	0.000251	CcSEcCtD
Glimepiride—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.82e-06	0.00025	CcSEcCtD
Glimepiride—Dyspnoea—Metformin—type 2 diabetes mellitus	9.79e-06	0.00025	CcSEcCtD
Glimepiride—Somnolence—Metformin—type 2 diabetes mellitus	9.76e-06	0.000249	CcSEcCtD
Glimepiride—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.75e-06	0.000249	CcSEcCtD
Glimepiride—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.74e-06	0.000248	CcSEcCtD
Glimepiride—Hypotension—Irbesartan—type 2 diabetes mellitus	9.68e-06	0.000247	CcSEcCtD
Glimepiride—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.67e-06	0.000247	CcSEcCtD
Glimepiride—Dyspepsia—Metformin—type 2 diabetes mellitus	9.66e-06	0.000246	CcSEcCtD
Glimepiride—Tremor—Ramipril—type 2 diabetes mellitus	9.6e-06	0.000245	CcSEcCtD
Glimepiride—Shock—Losartan—type 2 diabetes mellitus	9.59e-06	0.000245	CcSEcCtD
Glimepiride—Urticaria—Valsartan—type 2 diabetes mellitus	9.58e-06	0.000244	CcSEcCtD
Glimepiride—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.55e-06	0.000243	CcSEcCtD
Glimepiride—Decreased appetite—Metformin—type 2 diabetes mellitus	9.54e-06	0.000243	CcSEcCtD
Glimepiride—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.53e-06	0.000243	CcSEcCtD
Glimepiride—Tachycardia—Losartan—type 2 diabetes mellitus	9.52e-06	0.000243	CcSEcCtD
Glimepiride—Nausea—Bromocriptine—type 2 diabetes mellitus	9.49e-06	0.000242	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.48e-06	0.000242	CcSEcCtD
Glimepiride—Fatigue—Metformin—type 2 diabetes mellitus	9.46e-06	0.000241	CcSEcCtD
Glimepiride—Urticaria—Orlistat—type 2 diabetes mellitus	9.46e-06	0.000241	CcSEcCtD
Glimepiride—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.42e-06	0.00024	CcSEcCtD
Glimepiride—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.42e-06	0.00024	CcSEcCtD
Glimepiride—Asthenia—Gliclazide—type 2 diabetes mellitus	9.41e-06	0.00024	CcSEcCtD
Glimepiride—Agitation—Ramipril—type 2 diabetes mellitus	9.41e-06	0.00024	CcSEcCtD
Glimepiride—Angioedema—Ramipril—type 2 diabetes mellitus	9.36e-06	0.000239	CcSEcCtD
Glimepiride—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.3e-06	0.000237	CcSEcCtD
Glimepiride—Anorexia—Losartan—type 2 diabetes mellitus	9.29e-06	0.000237	CcSEcCtD
Glimepiride—Vomiting—Glyburide—type 2 diabetes mellitus	9.29e-06	0.000237	CcSEcCtD
Glimepiride—Pruritus—Gliclazide—type 2 diabetes mellitus	9.28e-06	0.000237	CcSEcCtD
Glimepiride—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.24e-06	0.000236	CcSEcCtD
Glimepiride—Rash—Glyburide—type 2 diabetes mellitus	9.21e-06	0.000235	CcSEcCtD
Glimepiride—Somnolence—Irbesartan—type 2 diabetes mellitus	9.21e-06	0.000235	CcSEcCtD
Glimepiride—Dermatitis—Glyburide—type 2 diabetes mellitus	9.2e-06	0.000235	CcSEcCtD
Glimepiride—Leukopenia—Ramipril—type 2 diabetes mellitus	9.17e-06	0.000234	CcSEcCtD
Glimepiride—Headache—Glyburide—type 2 diabetes mellitus	9.15e-06	0.000233	CcSEcCtD
Glimepiride—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.12e-06	0.000233	CcSEcCtD
Glimepiride—Hypotension—Losartan—type 2 diabetes mellitus	9.11e-06	0.000232	CcSEcCtD
Glimepiride—Palpitations—Ramipril—type 2 diabetes mellitus	9.05e-06	0.000231	CcSEcCtD
Glimepiride—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.05e-06	0.000231	CcSEcCtD
Glimepiride—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.01e-06	0.00023	CcSEcCtD
Glimepiride—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9e-06	0.00023	CcSEcCtD
Glimepiride—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.98e-06	0.000229	CcSEcCtD
Glimepiride—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.98e-06	0.000229	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.94e-06	0.000228	CcSEcCtD
Glimepiride—Fatigue—Irbesartan—type 2 diabetes mellitus	8.93e-06	0.000228	CcSEcCtD
Glimepiride—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.88e-06	0.000227	CcSEcCtD
Glimepiride—Convulsion—Ramipril—type 2 diabetes mellitus	8.87e-06	0.000226	CcSEcCtD
Glimepiride—Insomnia—Losartan—type 2 diabetes mellitus	8.82e-06	0.000225	CcSEcCtD
Glimepiride—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.78e-06	0.000224	CcSEcCtD
Glimepiride—Paraesthesia—Losartan—type 2 diabetes mellitus	8.75e-06	0.000223	CcSEcCtD
Glimepiride—Urticaria—Metformin—type 2 diabetes mellitus	8.72e-06	0.000222	CcSEcCtD
Glimepiride—Dyspnoea—Losartan—type 2 diabetes mellitus	8.69e-06	0.000222	CcSEcCtD
Glimepiride—Anxiety—Ramipril—type 2 diabetes mellitus	8.69e-06	0.000222	CcSEcCtD
Glimepiride—Nausea—Glyburide—type 2 diabetes mellitus	8.68e-06	0.000221	CcSEcCtD
Glimepiride—Abdominal pain—Metformin—type 2 diabetes mellitus	8.68e-06	0.000221	CcSEcCtD
Glimepiride—Dizziness—Gliclazide—type 2 diabetes mellitus	8.68e-06	0.000221	CcSEcCtD
Glimepiride—Somnolence—Losartan—type 2 diabetes mellitus	8.67e-06	0.000221	CcSEcCtD
Glimepiride—Asthenia—Valsartan—type 2 diabetes mellitus	8.65e-06	0.000221	CcSEcCtD
Glimepiride—Dyspepsia—Losartan—type 2 diabetes mellitus	8.58e-06	0.000219	CcSEcCtD
Glimepiride—Asthenia—Orlistat—type 2 diabetes mellitus	8.55e-06	0.000218	CcSEcCtD
Glimepiride—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.54e-06	0.000218	CcSEcCtD
Glimepiride—Pruritus—Valsartan—type 2 diabetes mellitus	8.53e-06	0.000218	CcSEcCtD
Glimepiride—Dry mouth—Ramipril—type 2 diabetes mellitus	8.53e-06	0.000218	CcSEcCtD
Glimepiride—Decreased appetite—Losartan—type 2 diabetes mellitus	8.48e-06	0.000216	CcSEcCtD
Glimepiride—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.47e-06	0.000216	CcSEcCtD
Glimepiride—Confusional state—Ramipril—type 2 diabetes mellitus	8.43e-06	0.000215	CcSEcCtD
Glimepiride—Pruritus—Orlistat—type 2 diabetes mellitus	8.43e-06	0.000215	CcSEcCtD
Glimepiride—Fatigue—Losartan—type 2 diabetes mellitus	8.41e-06	0.000214	CcSEcCtD
Glimepiride—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.36e-06	0.000213	CcSEcCtD
Glimepiride—Vomiting—Gliclazide—type 2 diabetes mellitus	8.34e-06	0.000213	CcSEcCtD
Glimepiride—Rash—Gliclazide—type 2 diabetes mellitus	8.27e-06	0.000211	CcSEcCtD
Glimepiride—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.27e-06	0.000211	CcSEcCtD
Glimepiride—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.25e-06	0.00021	CcSEcCtD
Glimepiride—Urticaria—Irbesartan—type 2 diabetes mellitus	8.23e-06	0.00021	CcSEcCtD
Glimepiride—Shock—Ramipril—type 2 diabetes mellitus	8.22e-06	0.00021	CcSEcCtD
Glimepiride—Headache—Gliclazide—type 2 diabetes mellitus	8.22e-06	0.00021	CcSEcCtD
Glimepiride—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.19e-06	0.000209	CcSEcCtD
Glimepiride—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.19e-06	0.000209	CcSEcCtD
Glimepiride—Tachycardia—Ramipril—type 2 diabetes mellitus	8.16e-06	0.000208	CcSEcCtD
Glimepiride—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.15e-06	0.000208	CcSEcCtD
Glimepiride—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.08e-06	0.000206	CcSEcCtD
Glimepiride—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.03e-06	0.000205	CcSEcCtD
Glimepiride—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.97e-06	0.000203	CcSEcCtD
Glimepiride—Dizziness—Valsartan—type 2 diabetes mellitus	7.97e-06	0.000203	CcSEcCtD
Glimepiride—Anorexia—Ramipril—type 2 diabetes mellitus	7.97e-06	0.000203	CcSEcCtD
Glimepiride—Dizziness—Orlistat—type 2 diabetes mellitus	7.88e-06	0.000201	CcSEcCtD
Glimepiride—Asthenia—Metformin—type 2 diabetes mellitus	7.88e-06	0.000201	CcSEcCtD
Glimepiride—Hypotension—Ramipril—type 2 diabetes mellitus	7.81e-06	0.000199	CcSEcCtD
Glimepiride—Nausea—Gliclazide—type 2 diabetes mellitus	7.79e-06	0.000199	CcSEcCtD
Glimepiride—Pruritus—Metformin—type 2 diabetes mellitus	7.77e-06	0.000198	CcSEcCtD
Glimepiride—Urticaria—Losartan—type 2 diabetes mellitus	7.75e-06	0.000198	CcSEcCtD
Glimepiride—Abdominal pain—Losartan—type 2 diabetes mellitus	7.71e-06	0.000197	CcSEcCtD
Glimepiride—Vomiting—Valsartan—type 2 diabetes mellitus	7.66e-06	0.000195	CcSEcCtD
Glimepiride—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.63e-06	0.000195	CcSEcCtD
Glimepiride—Rash—Valsartan—type 2 diabetes mellitus	7.6e-06	0.000194	CcSEcCtD
Glimepiride—Dermatitis—Valsartan—type 2 diabetes mellitus	7.59e-06	0.000194	CcSEcCtD
Glimepiride—Vomiting—Orlistat—type 2 diabetes mellitus	7.57e-06	0.000193	CcSEcCtD
Glimepiride—Insomnia—Ramipril—type 2 diabetes mellitus	7.56e-06	0.000193	CcSEcCtD
Glimepiride—Headache—Valsartan—type 2 diabetes mellitus	7.55e-06	0.000193	CcSEcCtD
Glimepiride—ABCC8—Metabolism—SLC5A2—type 2 diabetes mellitus	7.52e-06	0.000525	CbGpPWpGaD
Glimepiride—Diarrhoea—Metformin—type 2 diabetes mellitus	7.51e-06	0.000192	CcSEcCtD
Glimepiride—Rash—Orlistat—type 2 diabetes mellitus	7.51e-06	0.000192	CcSEcCtD
Glimepiride—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.51e-06	0.000191	CcSEcCtD
Glimepiride—Dermatitis—Orlistat—type 2 diabetes mellitus	7.5e-06	0.000191	CcSEcCtD
Glimepiride—Headache—Orlistat—type 2 diabetes mellitus	7.46e-06	0.00019	CcSEcCtD
Glimepiride—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.45e-06	0.00019	CcSEcCtD
Glimepiride—Asthenia—Irbesartan—type 2 diabetes mellitus	7.43e-06	0.00019	CcSEcCtD
Glimepiride—Somnolence—Ramipril—type 2 diabetes mellitus	7.43e-06	0.00019	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	7.42e-06	0.000518	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA6—type 2 diabetes mellitus	7.38e-06	0.000516	CbGpPWpGaD
Glimepiride—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.36e-06	0.000188	CcSEcCtD
Glimepiride—Pruritus—Irbesartan—type 2 diabetes mellitus	7.33e-06	0.000187	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—COX2—type 2 diabetes mellitus	7.29e-06	0.000509	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A2—type 2 diabetes mellitus	7.29e-06	0.000509	CbGpPWpGaD
Glimepiride—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.27e-06	0.000185	CcSEcCtD
Glimepiride—Dizziness—Metformin—type 2 diabetes mellitus	7.26e-06	0.000185	CcSEcCtD
Glimepiride—ABCC8—Metabolism—UCP3—type 2 diabetes mellitus	7.26e-06	0.000507	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—UCP2—type 2 diabetes mellitus	7.26e-06	0.000507	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD11B1—type 2 diabetes mellitus	7.26e-06	0.000507	CbGpPWpGaD
Glimepiride—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.22e-06	0.000184	CcSEcCtD
Glimepiride—Fatigue—Ramipril—type 2 diabetes mellitus	7.21e-06	0.000184	CcSEcCtD
Glimepiride—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.18e-06	0.000183	CcSEcCtD
Glimepiride—Nausea—Valsartan—type 2 diabetes mellitus	7.16e-06	0.000183	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—NCOA6—type 2 diabetes mellitus	7.16e-06	0.0005	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	7.13e-06	0.000498	CbGpPWpGaD
Glimepiride—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.09e-06	0.000181	CcSEcCtD
Glimepiride—Nausea—Orlistat—type 2 diabetes mellitus	7.08e-06	0.00018	CcSEcCtD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	7.04e-06	0.000492	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UCP2—type 2 diabetes mellitus	7.04e-06	0.000492	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD11B1—type 2 diabetes mellitus	7.04e-06	0.000492	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UCP3—type 2 diabetes mellitus	7.04e-06	0.000492	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	7.02e-06	0.00049	CbGpPWpGaD
Glimepiride—Asthenia—Losartan—type 2 diabetes mellitus	6.99e-06	0.000178	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.98e-06	0.000488	CbGpPWpGaD
Glimepiride—Vomiting—Metformin—type 2 diabetes mellitus	6.98e-06	0.000178	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.92e-06	0.000484	CbGpPWpGaD
Glimepiride—Rash—Metformin—type 2 diabetes mellitus	6.92e-06	0.000177	CcSEcCtD
Glimepiride—Dermatitis—Metformin—type 2 diabetes mellitus	6.92e-06	0.000176	CcSEcCtD
Glimepiride—Pruritus—Losartan—type 2 diabetes mellitus	6.9e-06	0.000176	CcSEcCtD
Glimepiride—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.89e-06	0.000176	CcSEcCtD
Glimepiride—Headache—Metformin—type 2 diabetes mellitus	6.88e-06	0.000175	CcSEcCtD
Glimepiride—Dizziness—Irbesartan—type 2 diabetes mellitus	6.85e-06	0.000175	CcSEcCtD
Glimepiride—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.84e-06	0.000174	CcSEcCtD
Glimepiride—ABCC8—Metabolism—PCK1—type 2 diabetes mellitus	6.82e-06	0.000477	CbGpPWpGaD
Glimepiride—Glyburide—CYP3A4—type 2 diabetes mellitus	6.72e-06	0.00606	CrCbGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.69e-06	0.000467	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	6.67e-06	0.000466	CbGpPWpGaD
Glimepiride—Diarrhoea—Losartan—type 2 diabetes mellitus	6.67e-06	0.00017	CcSEcCtD
Glimepiride—Urticaria—Ramipril—type 2 diabetes mellitus	6.64e-06	0.000169	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—PCK1—type 2 diabetes mellitus	6.62e-06	0.000462	CbGpPWpGaD
Glimepiride—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.61e-06	0.000169	CcSEcCtD
Glimepiride—Vomiting—Irbesartan—type 2 diabetes mellitus	6.59e-06	0.000168	CcSEcCtD
Glimepiride—Rash—Irbesartan—type 2 diabetes mellitus	6.53e-06	0.000167	CcSEcCtD
Glimepiride—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.53e-06	0.000166	CcSEcCtD
Glimepiride—Nausea—Metformin—type 2 diabetes mellitus	6.52e-06	0.000166	CcSEcCtD
Glimepiride—Headache—Irbesartan—type 2 diabetes mellitus	6.49e-06	0.000166	CcSEcCtD
Glimepiride—Dizziness—Losartan—type 2 diabetes mellitus	6.45e-06	0.000164	CcSEcCtD
Glimepiride—ABCC8—Metabolism—HK1—type 2 diabetes mellitus	6.39e-06	0.000447	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.25e-06	0.000437	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	6.21e-06	0.000434	CbGpPWpGaD
Glimepiride—Vomiting—Losartan—type 2 diabetes mellitus	6.2e-06	0.000158	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—HK1—type 2 diabetes mellitus	6.2e-06	0.000433	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD3B2—type 2 diabetes mellitus	6.17e-06	0.000431	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPA—type 2 diabetes mellitus	6.17e-06	0.000431	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCKR—type 2 diabetes mellitus	6.17e-06	0.000431	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—KCNJ11—type 2 diabetes mellitus	6.17e-06	0.000431	CbGpPWpGaD
Glimepiride—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.16e-06	0.000157	CcSEcCtD
Glimepiride—Nausea—Irbesartan—type 2 diabetes mellitus	6.15e-06	0.000157	CcSEcCtD
Glimepiride—Rash—Losartan—type 2 diabetes mellitus	6.15e-06	0.000157	CcSEcCtD
Glimepiride—Dermatitis—Losartan—type 2 diabetes mellitus	6.14e-06	0.000157	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	6.14e-06	0.000429	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	6.12e-06	0.000428	CbGpPWpGaD
Glimepiride—Headache—Losartan—type 2 diabetes mellitus	6.11e-06	0.000156	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	6.05e-06	0.000423	CbGpPWpGaD
Glimepiride—Asthenia—Ramipril—type 2 diabetes mellitus	6e-06	0.000153	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	5.99e-06	0.000418	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPA—type 2 diabetes mellitus	5.98e-06	0.000418	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCKR—type 2 diabetes mellitus	5.98e-06	0.000418	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD3B2—type 2 diabetes mellitus	5.98e-06	0.000418	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALDOB—type 2 diabetes mellitus	5.92e-06	0.000413	CbGpPWpGaD
Glimepiride—Pruritus—Ramipril—type 2 diabetes mellitus	5.91e-06	0.000151	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	5.9e-06	0.000412	CbGpPWpGaD
Glimepiride—Glyburide—ALB—type 2 diabetes mellitus	5.87e-06	0.00529	CrCbGaD
Glimepiride—Nausea—Losartan—type 2 diabetes mellitus	5.79e-06	0.000148	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ALDOB—type 2 diabetes mellitus	5.74e-06	0.000401	CbGpPWpGaD
Glimepiride—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.72e-06	0.000146	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.64e-06	0.000394	CbGpPWpGaD
Glimepiride—Dizziness—Ramipril—type 2 diabetes mellitus	5.53e-06	0.000141	CcSEcCtD
Glimepiride—ABCC8—Metabolism—GLP1R—type 2 diabetes mellitus	5.5e-06	0.000384	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GLP1R—type 2 diabetes mellitus	5.33e-06	0.000373	CbGpPWpGaD
Glimepiride—Vomiting—Ramipril—type 2 diabetes mellitus	5.32e-06	0.000136	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.29e-06	0.00037	CbGpPWpGaD
Glimepiride—Rash—Ramipril—type 2 diabetes mellitus	5.27e-06	0.000134	CcSEcCtD
Glimepiride—Dermatitis—Ramipril—type 2 diabetes mellitus	5.27e-06	0.000134	CcSEcCtD
Glimepiride—Headache—Ramipril—type 2 diabetes mellitus	5.24e-06	0.000134	CcSEcCtD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	5.19e-06	0.000363	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A2—type 2 diabetes mellitus	5.14e-06	0.000359	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	5.06e-06	0.000353	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CPT1A—type 2 diabetes mellitus	5.03e-06	0.000352	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTR—type 2 diabetes mellitus	5.03e-06	0.000352	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A2—type 2 diabetes mellitus	4.98e-06	0.000348	CbGpPWpGaD
Glimepiride—Nausea—Ramipril—type 2 diabetes mellitus	4.97e-06	0.000127	CcSEcCtD
Glimepiride—ABCC8—Metabolism—NAMPT—type 2 diabetes mellitus	4.93e-06	0.000345	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LIPC—type 2 diabetes mellitus	4.9e-06	0.000343	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HBA1—type 2 diabetes mellitus	4.9e-06	0.000343	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCK—type 2 diabetes mellitus	4.9e-06	0.000343	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CPT1A—type 2 diabetes mellitus	4.88e-06	0.000341	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTR—type 2 diabetes mellitus	4.88e-06	0.000341	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP11A1—type 2 diabetes mellitus	4.87e-06	0.00034	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	4.83e-06	0.000337	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	4.83e-06	0.000337	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	4.83e-06	0.000337	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC9A1—type 2 diabetes mellitus	4.79e-06	0.000334	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NAMPT—type 2 diabetes mellitus	4.78e-06	0.000334	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HBA1—type 2 diabetes mellitus	4.75e-06	0.000332	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LIPC—type 2 diabetes mellitus	4.75e-06	0.000332	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCK—type 2 diabetes mellitus	4.75e-06	0.000332	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CETP—type 2 diabetes mellitus	4.73e-06	0.000331	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP11A1—type 2 diabetes mellitus	4.72e-06	0.00033	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.7e-06	0.000329	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC9A1—type 2 diabetes mellitus	4.64e-06	0.000324	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.64e-06	0.000324	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CETP—type 2 diabetes mellitus	4.59e-06	0.000321	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PSMD6—type 2 diabetes mellitus	4.4e-06	0.000307	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SREBF1—type 2 diabetes mellitus	4.4e-06	0.000307	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SNAP25—type 2 diabetes mellitus	4.4e-06	0.000307	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.38e-06	0.000306	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CTGF—type 2 diabetes mellitus	4.32e-06	0.000302	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	4.3e-06	0.000301	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMGCR—type 2 diabetes mellitus	4.28e-06	0.000299	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SNAP25—type 2 diabetes mellitus	4.26e-06	0.000298	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PSMD6—type 2 diabetes mellitus	4.26e-06	0.000298	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SREBF1—type 2 diabetes mellitus	4.26e-06	0.000298	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.19e-06	0.000293	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADRA2A—type 2 diabetes mellitus	4.19e-06	0.000293	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CTGF—type 2 diabetes mellitus	4.19e-06	0.000292	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMGCR—type 2 diabetes mellitus	4.15e-06	0.00029	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADRA2A—type 2 diabetes mellitus	4.06e-06	0.000284	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2E1—type 2 diabetes mellitus	4.02e-06	0.000281	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A2—type 2 diabetes mellitus	3.98e-06	0.000278	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A1—type 2 diabetes mellitus	3.98e-06	0.000278	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2E1—type 2 diabetes mellitus	3.9e-06	0.000273	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP3A4—type 2 diabetes mellitus	3.88e-06	0.000271	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A2—type 2 diabetes mellitus	3.86e-06	0.000269	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A1—type 2 diabetes mellitus	3.86e-06	0.000269	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCG—type 2 diabetes mellitus	3.81e-06	0.000266	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.81e-06	0.000266	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP3A4—type 2 diabetes mellitus	3.76e-06	0.000263	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A4—type 2 diabetes mellitus	3.7e-06	0.000258	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCG—type 2 diabetes mellitus	3.7e-06	0.000258	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.66e-06	0.000256	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.66e-06	0.000256	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	3.59e-06	0.000251	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNB3—type 2 diabetes mellitus	3.29e-06	0.00023	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.29e-06	0.00023	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—type 2 diabetes mellitus	3.27e-06	0.000229	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAT—type 2 diabetes mellitus	3.23e-06	0.000226	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNB3—type 2 diabetes mellitus	3.19e-06	0.000223	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.19e-06	0.000223	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-06	0.000222	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	3.14e-06	0.000219	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	3.14e-06	0.000219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOB—type 2 diabetes mellitus	3.13e-06	0.000219	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAT—type 2 diabetes mellitus	3.13e-06	0.000219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—type 2 diabetes mellitus	3.05e-06	0.000213	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOB—type 2 diabetes mellitus	3.04e-06	0.000212	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPL—type 2 diabetes mellitus	2.99e-06	0.000209	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.98e-06	0.000208	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	2.97e-06	0.000208	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	2.97e-06	0.000208	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—type 2 diabetes mellitus	2.96e-06	0.000207	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADCY5—type 2 diabetes mellitus	2.93e-06	0.000205	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPX1—type 2 diabetes mellitus	2.92e-06	0.000204	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.91e-06	0.000203	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPL—type 2 diabetes mellitus	2.9e-06	0.000203	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.89e-06	0.000202	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD36—type 2 diabetes mellitus	2.84e-06	0.000199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-06	0.000198	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.84e-06	0.000198	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-06	0.000198	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.81e-06	0.000196	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.8e-06	0.000196	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD36—type 2 diabetes mellitus	2.76e-06	0.000193	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-06	0.00019	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—type 2 diabetes mellitus	2.69e-06	0.000188	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARA—type 2 diabetes mellitus	2.64e-06	0.000185	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.62e-06	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.62e-06	0.000183	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-06	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.61e-06	0.000182	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARA—type 2 diabetes mellitus	2.56e-06	0.000179	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGT—type 2 diabetes mellitus	2.56e-06	0.000179	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.56e-06	0.000179	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.54e-06	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.53e-06	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.53e-06	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.53e-06	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.53e-06	0.000177	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.53e-06	0.000177	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CALM1—type 2 diabetes mellitus	2.52e-06	0.000176	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOE—type 2 diabetes mellitus	2.51e-06	0.000175	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGT—type 2 diabetes mellitus	2.48e-06	0.000173	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA1—type 2 diabetes mellitus	2.48e-06	0.000173	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.45e-06	0.000171	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	0.000171	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOE—type 2 diabetes mellitus	2.43e-06	0.00017	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA1—type 2 diabetes mellitus	2.4e-06	0.000168	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.36e-06	0.000165	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.31e-06	0.000162	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.31e-06	0.000162	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.25e-06	0.000157	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—type 2 diabetes mellitus	2.18e-06	0.000153	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.15e-06	0.00015	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.15e-06	0.00015	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.15e-06	0.00015	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—type 2 diabetes mellitus	2.14e-06	0.00015	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-06	0.000148	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—type 2 diabetes mellitus	2.08e-06	0.000145	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.06e-06	0.000144	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.06e-06	0.000144	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.98e-06	0.000139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.98e-06	0.000139	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—type 2 diabetes mellitus	1.96e-06	0.000137	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.95e-06	0.000136	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.95e-06	0.000136	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.92e-06	0.000134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.92e-06	0.000134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.92e-06	0.000134	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	0.000133	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.88e-06	0.000131	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—type 2 diabetes mellitus	1.88e-06	0.000131	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.86e-06	0.00013	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	0.000127	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	0.000127	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.8e-06	0.000126	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.77e-06	0.000124	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.73e-06	0.000121	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—type 2 diabetes mellitus	1.72e-06	0.00012	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.69e-06	0.000118	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.68e-06	0.000118	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	0.000116	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.63e-06	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.63e-06	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.63e-06	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.63e-06	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.57e-06	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.56e-06	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.52e-06	0.000106	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.49e-06	0.000104	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.47e-06	0.000103	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.45e-06	0.000101	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.36e-06	9.47e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.33e-06	9.28e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.33e-06	9.28e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.3e-06	9.1e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.29e-06	9.05e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.29e-06	9.04e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.29e-06	9.04e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.29e-06	9.04e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.29e-06	8.99e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.26e-06	8.82e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.25e-06	8.72e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.16e-06	8.13e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.16e-06	8.11e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.16e-06	8.11e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.16e-06	8.11e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.14e-06	7.96e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.13e-06	7.89e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.11e-06	7.78e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.1e-06	7.72e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.06e-06	7.42e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.05e-06	7.33e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.05e-06	7.33e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.02e-06	7.15e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.02e-06	7.12e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.01e-06	7.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.01e-06	7.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.67e-07	6.06e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.67e-07	6.06e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	8.64e-07	6.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.63e-07	6.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.52e-07	5.95e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	8.37e-07	5.85e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.27e-07	5.78e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.04e-07	5.62e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.9e-07	5.52e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.73e-07	5.4e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.7e-07	5.38e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.5e-07	5.24e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.41e-07	5.18e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.11e-07	4.97e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.97e-07	4.87e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.76e-07	4.72e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.64e-07	4.64e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.62e-07	4.62e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.54e-07	4.57e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.77e-07	4.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.65e-07	3.95e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.18e-07	3.62e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.96e-07	3.46e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.96e-07	3.46e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.54e-07	3.17e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.28e-07	1.59e-05	CbGpPWpGaD
